Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Case of Terbinafine-Resistant Tinea Cruris Caused by Trichophyton Tonsurans Publisher



Firooz A1 ; Lotfali E2 ; Fattahi M1 ; Fattahi M1 ; Miramin Mohammadi A1 ; Shahrzad Kavkani M4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Medical Parasitology and Mycology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  3. 3. Emergency Medicine Management Research Center, Iran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Microbial Biotechnology, Islamic Azad University, Damghan, Iran

Source: Case Reports in Dermatological Medicine Published:2021


Abstract

A 26-year-old male patient referred to our center with a history of extremely itchy crusted skin lesions in his groins for one year. Moreover, his friend, a 25-year-old male, also developed similar lesions in the groin after using the shared pool, whose condition also did not improve with similar treatment. A regular mycology test (direct and culture test) was performed, as well as molecular examination. The antifungal susceptibility assay to terbinafine, itraconazole, posaconazole, fluconazole, and voriconazole was conducted according to the Clinical and Laboratory Standards Institute M38 third ed. The sequencing study identified T. tonsurans as the causative organism in both patients. The abovementioned organism isolated from both patients displayed resistance against terbinafine and fluconazole (MIC ≥ 4 μg/ml and MIC ≥ 8 μg/ml, respectively). Moreover, the susceptibility of both subjects to posaconazole (0.313 μg/ml), voriconazole (0.25-0.0625 μg/ml), and (1 μg/ml) itraconazole increased. The present report aimed to emphasize the increase in antifungal resistance and a demand for antifungal stewardship, to control this public health threat. © 2021 Alireza Firooz et al.